Abstract:Aprotinin is a 58 amino acid bovine protease inhibitor which inhibits a range of serine proteases including trypsin,chymotrypsin,plasmin,kallikrein and trombin.This single-chain polypeptide with the molecular mass of 6.5 kDa and the PI of 10.5 is crosslinked by three disulphide-bond bridges.It was initially isolated from bovine pancreas by Kunitz and Northrop.Aprotinin has been widely used in various fields.It can be used as inhibitor in protein purification procedure and tissue culture to prevent the degradation.In clinical use,because of its antifibrinolytic properties,aprotinin can be used in cardiac surgery to decrease postoperative blood loss and preserve platelet function during cardiopulmonary bypass.Due to the large requirement of aprotinin,the methods to produce aprotinin with high homogeneity and yields have been studied.Most of the reports regarding this topic are about purification of aprotinin from bovine tissues.But these purification procedures are complicated and costly.So the development of effective recombinant expression system is necessary.In this study,the deoxyoligonucleotide encoding aprotinin was synthesized according to the codon prefernce of E.coli.The DNA sequence was amplified by PCR and inserted into the expression vector pET28a between the NdeI and XhoI sites.The recombinant expression plasmid was then transformed into E.coli strain Rosetta(DE3),and recombinant aprotinin(r-aprotinin) was expressed as inclusion body by IPTG induction.The amount of r-aprotinin expressed accounted for 8%～10% of the total bacterial protein.After purification of inclusion body,renaturation and CM cation-exchange chromatography,2.4 mg r-aprotinin was obtained from one liter of shaking flask culture of E.coli with homogeneity greater than 90%.Kinetic studies demonstrated that r-aprotinin competitively inhibited the amidolytic activity of plsamin against small substrate S2251. The inhibition constant(Ki) was(0.6±0.3) nmol/L,which was similar to that of the native aprotinin.

RNA Aptamers Specific for Bovine Thrombin.

Screening of Functional Antidotes of RNA Aptamers Against Bovine Thrombin

An Antibody That Binds To Primary Specific Pocket-Associated Structure In The Active Site Of Bovine Thrombin

Molecular assembly for high-performance bivalent nucleic acid inhibitor

Label-free aptamer biosensor for selective detection of thrombin

Rational Design of Antibody Protease Inhibitors.

Functional expression of a thrombin exosite I inhibitor triabin in Escherichia coli and elucidation of the role of key residues in its inhibitory activity

Characterisation of Ag1, the major species-specific contaminant of bovine crude heparin, and its identification as an aprotinin/heparin complex

Development and optimization of a DNA aptamer to delay β-bungarotoxin-induced lethality in a rodent model

Selection of an Aptamer Antidote to the Anticoagulant Drug Bivalirudin

Evolution of a highly functional circular DNA aptamer in serum

Selection, identification, and application of DNA aptamers against bovine pregnancy-associated glycoproteins 4

RNA Aptamers for a tRNA-Binding Protein from Aeropyrum pernix with Homologous Counterparts Distributed Throughout Evolution

Antithrombotic but not anticoagulant activity of the thrombin‐binding RNA aptamer Apta‐1

Bovine Thrombin Enhances the Efficiency and Specificity of Polymerase Chain Reaction

Regulation of thrombin activity with a bifunctional aptamer and hemin: development of a new anticoagulant and antidote pair.

Recognition of Bungarus Multicinctus Venom by a DNA Aptamer Against Β-Bungarotoxin

BJTJ-1837, a novel FXI activation-blocking antibody

Expression of Recombinant Aprotinin in E.coli and the Identification of Its Biological Activity

Aptamer Binding Assays for Proteins: the Thrombin Example--a Review.

Alkylation of Phosphorothioated Thrombin Binding Aptamers Improves the Selectivity of Inhibition of Tumor Cell Proliferation Upon Anticoagulation.